Ritter Pharmaceuticals | Therapeutic Treatments for Gastrointestinal Diseases

Partnership Opportunities

Ritter is actively seeking a strategic alliance partner for its promising product, RP-G28, to treat lactose intolerance. Ritter also seeks partnership opportunities for compounds developed to treat and/or prevent a wide variety of gastrointestinal diseases. For more information, please contact:

Bryan Jones
Chief Business Officer
Bryan@ritterpharma.com